Pulmonary hypertension (PH) is a complex, multifaceted disorder that requires a comprehensive understanding for effective management. This article aims to provide a concise overview of the fundamentals of PH, including pathophysiology, diagnosis, and treatment strategies.
PH is characterized by increased pressure in the pulmonary arteries. The pathogenesis involves endothelial dysfunction, smooth muscle cell proliferation, and inflammation, leading to vascular remodeling and increased pulmonary vascular resistance. This results in right ventricular overload, which can progress to right heart failure if left untreated.
Diagnosing PH is a multistep process that starts with a high index of suspicion based on symptoms and risk factors. Non-invasive tests such as echocardiography are often the first step, followed by confirmatory right heart catheterization. Diagnostic imaging and laboratory tests are also used to identify the underlying cause and guide treatment.
Treatment of PH is directed at the underlying cause and aimed at reducing pulmonary artery pressure, improving symptoms, and slowing disease progression. Therapeutic options include vasodilators, anticoagulants, diuretics, and oxygen therapy. In severe cases, lung transplantation may be considered.
Management of PH requires a multidisciplinary approach involving cardiologists, pulmonologists, radiologists, and other specialists. This collaborative approach ensures comprehensive patient care and optimizes outcomes.
Understanding the fundamentals of PH is essential for its effective management. With a solid grasp of its pathophysiology, diagnostic strategies, and treatment options, healthcare professionals can significantly improve patient outcomes in this complex disorder.
1.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
2.
Mezigdomide Combinations Show Promise in Multiple Myeloma
3.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
4.
Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.
5.
Oleanolic acid from grapes may increase chemotherapy effectiveness
1.
Advanced Approaches in Oncology and Patient Outcomes
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
Emerging Advances in Hematology and Quality Improvement
4.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
5.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part XIV
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation